Roche Diagnostics

Roche Diagnostics is the diagnostics division of F. Hoffmann-La Roche AG, a Swiss multinational healthcare company founded in 1896 and headquartered in Basel, Switzerland. It is recognized as the world leader in in vitro diagnostics and tissue-based cancer diagnostics.

The division develops and produces medical tests and digital tools across a broad range of areas, including molecular diagnostics, clinical chemistry, immunoassays, tissue diagnostics, point-of-care testing, patient self-testing, next-generation sequencing, laboratory automation and IT, and decision-support solutions. Its products and services are available in more than 100 countries, helping healthcare professionals identify the right treatments and improve patient outcomes.

Roche Diagnostics reported sales of CHF 14.32 billion in 2024, with its base business growing 8 percent at constant exchange rates, driven largely by demand for immunodiagnostic products. Roche as a whole employs approximately 112,774 people globally, with Roche Diagnostics USA headquartered in Indianapolis, Indiana.

As an organization at the intersection of laboratory science, digital health, and precision medicine, Roche Diagnostics is highly relevant to innovations in diagnostic technologies, healthcare data analytics, and clinical decision support. The company has also committed to halving the environmental impact of its operations and products between 2019 and 2029.